Related references
Note: Only part of the references are listed.Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guerin
Ashish M. Kamat et al.
EUROPEAN UROLOGY (2016)
NMP22 is predictive of recurrence in high-risk superficial bladder cancer patients
Paul Lau et al.
CUAJ-Canadian Urological Association Journal (2016)
Biomarkers for detection and surveillance of bladder cancer
Lorne I. Budman et al.
CUAJ-Canadian Urological Association Journal (2016)
Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer
Tilman Todenhoefer et al.
BMC CANCER (2015)
Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer
Faysal A. Yafi et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
The Use of Urinary Nuclear Matrix Protein 22 (NMP22) as a Diagnostic Adjunct to Urine Cytology for Monitoring of Recurrent Bladder Cancer-Institutional Experience and Review
Binnur Onal et al.
DIAGNOSTIC CYTOPATHOLOGY (2015)
Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer
Faysal A. Yafi et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Epidemiology and Risk Factors of Urothelial Bladder Cancer
Maximilian Burger et al.
EUROPEAN UROLOGY (2013)
Impact of different grades of microscopic hematuria on the performance of urine-based markers for the detection of urothelial carcinoma
Tilman Todenhoefer et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Overestimation of Nuclear Matrix Protein 22 in Concentrated Urine
Jae Young Joung et al.
UROLOGY (2013)
Urinary Tumor Markers Could Predict Survival in Bladder Carcinoma
Ragaa H. M. Salama et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2013)
Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guerin Therapy for Bladder Cancer: Results of a Prospective Trial
Ashish M. Kamat et al.
JOURNAL OF UROLOGY (2012)
Influence of Urinary Tract Instrumentation and Inflammation on the Performance of Urine Markers for the Detection of Bladder Cancer
Tilman Todenhoefer et al.
UROLOGY (2012)
Influencing factors on the NMP-22 urine assay: an experimental model
Makito Miyake et al.
BMC UROLOGY (2012)
Assessing the Clinical Benefit of Nuclear Matrix Protein 22 in the Surveillance of Patients With Nonmuscle-Invasive Bladder Cancer and Negative Cytology
Shahrokh F. Shariat et al.
CANCER (2011)
Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy
Wassim Kassouf et al.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2010)
Accuracy of Urine Cytology and the Significance of an Atypical Category
Fadi Brimo et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update
M. Craig Hall et al.
JOURNAL OF UROLOGY (2007)
Clinical model of lifetime cost of treating bladder cancer and associated complications
Elenir B. C. Avritscher et al.
UROLOGY (2006)
Urine markers for bladder cancer surveillance: A systematic review
BWG van Rhijn et al.
EUROPEAN UROLOGY (2005)
Urinary markers of bladder carcinoma
P Dey
CLINICA CHIMICA ACTA (2004)
Non-invasive urothelial neoplasms: According to the most recent WHO classification
A Lopez-Beltran et al.
EUROPEAN UROLOGY (2004)
Sensitivity and specificity of commonly available bladder tumor markers versus cytology: Results of a comprehensive literature review and meta-analyses
Y Lotan et al.
UROLOGY (2003)
Primary superficial bladder cancer risk groups according to progression, mortality and recurrence
F Millan-Rodriguez et al.
JOURNAL OF UROLOGY (2000)
Share Paper
